Ms. Crawford joined Exponent in 2005 and in her role as Project Manager within the Biocides Team she has assisted clients with both the EU Biocidal Products Regulation (BPR) and Biocidal Products Directive (BPD) legislation. She has represented clients at Working Group (Technical) and CA meetings, liaised with regulatory authorities, (within the EU and globally) and prepared and submitted dossiers for active substances and biocidal products under EU and national legislation, globally. She has successfully placed and monitored studies and has proven success in achieving biocide dossier completeness, active substance approvals/Annex I inclusions and product authorisations.
Ms. Crawford gained her B.Sc. Honours degree in Biophysics from Leeds University in 1982, and then worked as a Project Manager in clinical research for over 17 years.
Under the Plant Protection Products Directive and Plant Protection regulation, Ms. Crawford has been involved in preparing and submitting dossiers for Annex I approval/listing on the List of approved active substances and providing regulatory support to clients through the EU review process. She has several years of experience of liaising with and supporting Taskforces, monitoring budgets, and extensive experience in being the focal point for projects and ensuring that effective lines of communication between Exponent’s team of technical experts and the client are established and maintained.
Prior to joining Exponent, Ms. Crawford managed European multi-centre clinical trials, which involved performing feasibility and risk assessments, tracking timelines and budgets, and co-ordinating activities within a leading Contract Research Organisation and various external sub-contractors. She was also part of the Taskforce involved in implementing the European Clinical Trial Directive 2001/20/EEC throughout a global Contract Research Organisation.
CREDENTIALS & PROFESSIONAL HONORS
- M.Sc., Physical Chemistry/Clinical Biochemistry, Newcastle University, UK, 1985
Churchouse SJ, Mullen WH, Keedy FH, Vadgama PM. Studies on needle glucose electrodes. Anal Proc 1986; 23:146–148.
Mullen WH., Churchouse SJ, Keedy FH, Vadgama PM. Blood glucose determination using an enzyme electrode based on the Quinoprotein, Glucose Dehydrogenase. Anal Proc 1986; 23:145–146.
Mullen WH, Churchouse SJ, Keedy FH, Vadgama PM. Enzyme electrode for the measurement of Lactate in undiluted blood. Clin Chem Acta 1986; 157:191–198.
Mullen WH, Keedy FH, Churchouse SJ, Vadgama PM. Glucose enzyme electrode with extended linearity; application to undiluted blood measurement. Anal Chem Acta 1986; 183:59–66.
Crawford FH. Ethics and clinical trials. Certificate in Clinical Research, Leeds University, May 2004.
Crawford FH. Awareness on European clinical trials Directive 2001/20/EC. Covance, March 2004.
Crawford FH. All you ever wanted to know about monitoring but were afraid to ask. Certificate in Clinical Research, Leeds University, June 2003.
Crawford FH. Protocol development. Certificate in Clinical Research, Leeds University, June 2001.
Churchouse SJ, Mullen WH, Keedy FH, Vadgama PM. Studies on needle glucose electrodes. 30th International Congress of Pure and Applied Chemistry, Manchester, UK, September 8–13, 1985.
Mullen WH, Churchouse SJ, Keedy FH, Vadgama PM. Blood glucose determination using an enzyme electrode based on the Quinoprotein, glucose Dehydrogenase. 30th International Congress of Pure and Applied Chemistry, Manchester, UK, September 8–13, 1985.
Project Manager for Phase I and IIa Clinical Trials, Covance Clinical Research Unit, Leeds, UK, 1987–2005
Company Management Representative ISO 9001 Covance Clinical Research Unit, Leeds, UK, 1997–2001
Pharmaceutical Documentation Officer, Glaxo, Barnard Castle, UK, 1987
Clinical Research Associate Sterling-Winthrop Research Centre, Alnwick, UK, 1986–1987
Institute of Clinical Research, (member) 2002